The biobank consent debate: why 'meta-consent' is still the solution!

Area of Science:

• Bioethics
• Medical Law and Ethics
• Genomic Research Ethics

Background:

• The ethics of informed consent for biobank participation remain a contentious issue.
• Neil Manson's recent article in the Journal of Medical Ethics critiques the meta-consent model.
• Manson argues against meta-consent, proposing broad consent as a more acceptable alternative.

Purpose of the Study:

• To critically evaluate Manson's arguments against the meta-consent model.
• To demonstrate the limitations and inaccuracies in Manson's analysis of meta-consent and broad consent.
• To advocate for the meta-consent model as a superior framework for biobank ethics.

Main Methods:

• A critical analysis of Manson's arguments regarding the costs and moral acceptability of meta-consent.
• A re-evaluation of the analogy used to support broad consent in biobanking.
• A philosophical argument for the alignment of meta-consent with the realities of biobank research.

Main Results:

• Manson's assessment of the costs associated with meta-consent is incomplete and misleading.
• The analogy supporting broad consent misrepresents the operational realities of biobank research.
• The meta-consent model is more congruent with the nature of biobank research.

Conclusions:

• The meta-consent model is a more ethically sound approach for informed consent in biobank participation.
• Meta-consent enhances autonomous choice for participants in biobank research.
• Further consideration of meta-consent is warranted to address ongoing ethical debates in biobanking.